CATALYST_TYPE
saveCRL (Complete Response Letter)
FDA letter declining approval and identifying deficiencies.
also known as: crl, complete response letter
🐶 often sniffed alongside
top 4drugs
0
catalysts
0
news
122
companies
0
Top drugs
no drugs tagged with this interest yet
🐶 Top companies
no companies tagged with this interest yet
Recent catalysts
no catalysts tagged with this interest yet
Recent news
view all →- Atara, Pierre Fabre resubmit twice-rebuffed cell therapy after FDA flips againbiospace · 5d ago
- Analysts ‘extremely bullish’ as Telix beams into Novartis’ territory with $1.6B ITM acquisitionfiercebiotech · 14d ago
- REGENXBIO’s Hunter syndrome gene therapy hit by FDA hold, stymieing resubmission plansbiospace · 1mo ago
- Ultragenyx bags first gene therapy approval as previously rejected Sanfilippo asset awaits decisionbiospace · 1mo ago
- Medigen links up with Charles River in push to take enterovirus vaccine globalfiercebiotech · 1mo ago
- Trump picks White House aide Heidi Overton as FDA chief: Reportsbiospace · 1mo ago
- Nascent US psychedelic therapy opportunity attracts overseas manufacturersbiospace · 1mo ago
- FDA rejects ITM Isotope’s radiopharma therapy over manufacturing issuesbiospace · 1mo ago
Data sources
last refreshed 4h ago
Found something off?
comments(0)
5-min edit window · permanent after that